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Peritoneal Perfusion With Oxygenated
Perfluorocarbon Augments Systemic
Oxygenation*
Shamus R. Carr, MD; Joshua P. Cantor, MD; Atul S. Rao, MD;
Thiru V. Lakshman, MD; Joshua E. Collins, BS; and Joseph S. Friedberg, MD
Background: Despite maximal ventilatory support, many patients die from hypoxia in the setting
of potentially reversible pulmonary failure. There remains a pressing need for additional
pulmonary supportive care measures, especially techniques that do not require systemic
anticoagulation. The objective of our experiments was to determine whether systemic oxygen-
ation could be increased in a large animal, with induced hypoxia, by perfusing the abdominal
cavity with oxygenated perfluorocarbons.
Methods: Fifteen pigs with a mean ( SD) weight of 45  5 kg were intubated and rendered
hypoxic by ventilating them with a blend of nitrogen and oxygen to achieve subatmospheric
concentrations of inspired oxygen ranging from 18 to 10%, resulting in baseline mean PaO2 range
of 65.9  9.7 to 26.6  2.8 mm Hg, respectively. Peritoneal perfusion was performed in eight
animals with oxygenated perfluorocarbon and in seven control animals with oxygenated saline
solution.
Results: The average increase in PaO2 with oxygenated perfluorocarbon perfusion, compared to
oxygenated saline solution perfusion, ranged from 8.1 to 18.2 mmHg. A common treatment effect
was estimated across all fraction of inspired oxygen (FIO2) values, representing the average mean
difference in oxygen uptake between oxygenated perfluorocarbon and saline solution, irrespec-
tive of the level of FIO2. This average was 12.8 mm Hg (95% confidence interval, 7.4 to 18.2;
p < 0.001). The most clinically relevant results occurred at an FIO2 of 14%, resulting in a baseline
mean PaO2 of 39.4  5.0 mm Hg with oxygenated saline solution perfusion, and a mean PaO2 of
55.3  7.6 mm Hg with oxygenated perfluorocarbon perfusion. This corresponded to an increase
in arterial oxygen saturation from 73 to 89%.
Conclusion: These results of our principle experiments demonstrate that the peritoneal cavity can
be used for gas exchange and, in our model, yielded clinically relevant increases in systemic
arterial oxygen levels. This technique may have the potential for the supportive care of patients
dying from hypoxia in the setting of reversible lung injury. (CHEST 2006; 130:402–411)
Key words: animals; ARDS; artificial respiration; extracorporeal membrane oxygenation; fluorocarbons; respiratory
insufficiency
Abbreviations: CI  confidence interval; Fio2  fraction of inspired oxygen; psi pounds per square inch;
Sao2  arterial oxygen saturation
P otentially reversible pulmonary failure secondaryto diseases such as avian flu, ARDS, severe acute
respiratory syndrome, pulmonary embolism, and
bacterial pneumonia claims many lives in the United
States every year.1 In addition to this already formi-
dable population, we now live in a world where the
specter of bioterrorism with an aerosolized agent
could multiply this number many fold at any time,
literally overnight. Although multiorgan failure may
result in the demise of a patient with any of these
conditions, many patients die from isolated pulmo-
nary insufficiency that is potentially reversible. The
high mortality and increasing size of this population
underscores the need for new and improved treat-
ments for potentially reversible pulmonary failure.
Supportive care with mechanical ventilation is the
cornerstone of all treatment strategies for patients
with severe pulmonary failure. Numerous modes and
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parameters of mechanical ventilation can be adjusted
in an effort to maximize gas exchange, but when
these manipulations are no longer effective the
clinician is left with very few options. Extracorporeal
membrane oxygenation is a well-established and
effective technique to supplement pulmonary func-
tion. This modality, however, is a scarce resource
that requires special expertise to institute and trained
personnel to manage, and, primarily due to the need
for systemic anticoagulation, is accompanied by its
own set of morbidities and limitations.2–10 Liquid
ventilation, an attempt to improve the gas exchange
capacity of diseased lungs by filling them with a
gas-transporting fluid (perfluorocarbons), is an ex-
perimental modality that has yet to establish itself as
a mainstream therapeutic option.11,12
Perfluorocarbons are inert, colorless, clear, non-
toxic, fluorine-based organic compounds with ex-
traordinary gas-dissolving properties. The solubility
of O2 and CO2 in perfluorocarbons is typically in the
range of 50 mL of gas per 100 mL of liquid and 200
mL of gas per 100 mL of liquid at 37°C, respectively.
For comparison, the respective solubility of O2 and
CO2 in saline solution at 37°C is 3 mL of gas per 100
mL of liquid and 57 mL of gas per 100 mL of
liquid.13–17
The concept we wished to explore was whether it
was possible to use the peritoneal membrane for gas
exchange, which is analogous to the way in which this
same surface can be used for solute and fluid
exchange with peritoneal dialysis. It has been shown
that significant oxygenation can be achieved in small
rodents by filling the abdominal cavity with oxygen-
ated saline solution or gaseous oxygen, but this effect
has not been replicated in large-animal models.18,19
It is thought that the relative decrease in the perito-
neal surface area, with increasing animal size, is
responsible for this loss of effect.20 Our hypothesis
was that using perfluorocarbons for gas exchange, in
a perfusion circuit that maintains a high oxygen
gradient, might overcome the limitation of a rela-
tively smaller peritoneal surface area and permit
significant levels of oxygen exchange in a large
animal. To test this hypothesis, for proof of principle,
we designed a large animal-induced hypoxia model.
Materials and Methods
Animals
Fifteen Sus scrofa pigs with a mean ( SD) weight of 45 5
kg were used for the experiments. All experiments were approved
by the Thomas Jefferson University Institutional Animal Care
and Use Committee. The care and handling of all animals were in
accord with US Department of Agriculture guidelines.
Surgical Procedure
Anesthesia was induced in the animals with tiletamine hydro-
chloride (Telazol; Fort Dodge Animal Health; Fort Dodge, IA),
5 mg/kg, injected IM, after which an IV catheter was placed in an
ear vein and 30 mg of propofol (Baxter; Irvine, CA) was injected
IV. The animals were then intubated with an endotracheal tube
having a 7.5-mm internal diameter (Mallinckrodt Inc; St. Louis,
MO) and maintained with isoflurane inhalation anesthesia, using
intermittent propofol injections for any evidence of discomfort or
awakening. The animals were placed on a mechanical ventilator
(Dual Phase Control Respirator Pump; Harvard Apparatus;
Holliston, MA) with a tidal volume of 10 to 15 mL/kg and a rate
of 12 to 15 breaths/min. Prior to subjecting the animal to hypoxia,
the respiratory rate was occasionally adjusted in an effort to
maintain a neutral pH, as determined by arterial blood gas
measurements. ECG leads were placed in the standard three-
lead positions on each animal, starting at the time of induction,
and were continuously monitored throughout the experiment.
Oxygen saturation was also measured with a pulse oximeter
(Vet/Ox Plus 4700; SDI; Waukesha, WI) with the probe placed
on the tongue of the animal. Once under general anesthesia and
in the supine position, a cervical cut down was performed
through which a Swan-Ganz right heart catheter (Edwards
Lifesciences; Irvine, CA) was placed via the internal jugular vein,
and an 18-gauge angiocatheter was placed in the common carotid
artery for access to the central arterial system for BP monitoring
and arterial blood gas measurements. Both of these lines were
transduced using a pressure-monitoring kit with a pressure
transducer (TruWave; Edwards Lifesciences) that was connected
to a monitor system (model 78834A; Hewlett-Packard; Palo Alto,
CA) for monitoring the systemic and pulmonary arterial pressures
and the central venous pressure.
After placement of the arterial and venous lines, a midline
laparotomy was performed. A 28F venous return cannula cathe-
ter (Edwards Lifesciences) was placed in the left paracolic gutter,
brought out through a separate site in the left lower quadrant,
and sutured in place using a No. 1 polypropylene suture (Prolene
suture; Ethicon; Sommerville, NJ). A 42F venous return cannula
(Edwards Lifesciences) was placed in an identical manner on the
right side, with the tip lodged above the dome of the liver. The
abdomen was then closed in a single layer with a running No. 1
polypropylene suture. In the first two animals in each experimen-
tal group, an additional 14F catheter (Edwards Lifesciences) was
placed near the midline for pressure-monitoring purposes and
was maintained in a vertical attitude, attached to a ruler such that
the height of the column of fluid could be easily monitored.
Peritoneal pressure measurements (expressed in centimeters of
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H2O) were calculated by multiplying column height by the
correction factor 1.67 (specific gravity of trans-bis-perfluorobutyl
ethylene).
Hypoxia Circuit
A anesthesia machine (Matrx; Orchard Park, NY) was used for
blending gases and isoflurane-inhaled anesthetic. Pure nitrogen,
rather than filtered room air, was mixed with pure oxygen to
achieve subatmospheric concentrations of oxygen. The animal
was ventilated using a standard bifurcated anesthesia circuit to
maintain a unidirectional flow of the gases. A machine (Datex;
Puritan-Bennett Corporation; Overland Park, KS) was attached
to the ventilation circuit that allowed real-time monitoring of the
oxygen and anesthetic agent concentrations. The oxygen and
nitrogen tanks were connected to the circuit through a flowmeter
(Matrx). The probe of the flowmeter was placed at the origin of
the endotracheal tube, allowing for accurate determination of the
respective flows of oxygen and nitrogen required to achieve the
desired Fio2.
Peritoneal Circulation Circuit
The 42F venous return cannula, which was used to recover the
perfusate from the abdomen, was connected to a 127 cm length
of three eighths inch (internal diameter) tubing (Gish Biomedi-
cal; Rancho Santa Margarita, CA). This tubing was connected to
a No. 10 filter housing (Clear Cold Water Filter Housing; Filter
Store, Inc.; Mendon, NY) containing a 50-m pleated filter
(Filter Store, Inc). After passing through the filter, the outflow
drained by gravity into a custom built 10-L glass tank (Advanced
Aquatanks; Los Angeles, CA). The outflow of the filter was placed
41 cm below the level of the operating table. A ceramic plate
diffuser (Aquaculture Technology; Kitzbuhel, Austria) was placed
at the bottom of the collection tank. This diffuser was designed
for oxygenating ponds and gives off a steady stream of 10 to 200
m bubbles when being infused with oxygen at 30 pounds per
square inch (psi) [based on product information from the com-
pany]. This diffuser was connected to a medical oxygen tank via
one quarter inch (internal diameter) tubing (Gish Biomedical).
The gauge on the tank was able to measure the oxygen delivered
to the diffuser in psi. (A standard cardiopulmonary bypass “lung”
cannot be used to oxygenate perfluorocarbon as the liquid is able
to pass through hollow fibers.)
Fluid was retrieved from the collecting tank with a 150-cm
length of one quarter inch tubing that was connected to a piece
of three eighths inch tubing that passed through a pump (Roller
Blood Pump; Sarns, Inc; Ann Arbor, MI) that was used to control
the flow rate. This outflow from the roller pump passed into a
43-cm length of one quarter inch tubing. This tubing was
connected to the inflow end of a heat exchanger (ECMOtherm-
II; Avecor; Minneapolis, MN). The heat exchanger was set to
warm the abdominal perfusate to 39°C, which is normal body
temperature for swine. This was accomplished using a circulatory
heater (Haake; Berlin, Germany). After being warmed by the
heat exchanger, the abdominal perfusate passed through a 63-cm
length of one quarter inch tubing to the 28F inflow catheter. All
tubing was standard cardiopulmonary bypass tubing. Thus, the
circuit was as follows: abdomen, outflow catheter, filter, reservoir
with oxygenator, pump, warmer, inflow catheter, and abdomen.
Establishing Flow Rate and Priming Circuit
After the cannulas were placed and the abdomen was closed, it
was necessary to assure that the circuit was functional before
initiating the progressive hypoxia sequence. Any perfusion circuit
that is dependent on a siphon phenomenon for outflow may
require manipulation of the outflow catheter to achieve optimal
flow due to local geometric factors that can obstruct or occlude
the catheter drainage ports. Through trial and error, we found
that placing the outflow cannula above the liver yielded the
fewest drainage problems. With the cannula in this location, it
was never necessary to reopen the incision, but occasionally it was
necessary to spin the catheter or move it several centimeters in or
out to assure optimal flow.
The reservoir was initially primed with 8 L of perfusate. Once
the circuit was flowing smoothly, the inflow pump was adjusted to
match the maximum outflow rate for that animal. This rate was
empirically determined and unique for each animal, falling
between 1.2 and 4.2 L/min (Table 2). Once optimization of the
circuit was complete and the maximum flow rate for that animal
was identified, the outflow catheter was clamped and the abdo-
men was allowed to fill with 5 to 7 L of fluid. Once this volume
was infused into the abdomen, the inflow catheter was then
clamped, thereby trapping the perfusate in the abdomen. In
designing this model, we found that this maneuver, which did not
affect the intraabdominal pressure, was necessary in order to
assure that the siphon would resume and that the circuit could be
restarted after having been stopped for several hours during the
stepwise hypoxia portion of the experiments. Thus, in every case
there was a large volume of perfusate, saline solution, or perfluo-
rocarbon harbored in the abdomen during the collection of the
“circuit-off” hypoxia measurements.
Perfluorocarbon
Seventy liters of neat perfluorocarbon F44E (trans-bis-perflu-
orobutyl ethylene) were provided as a generous gift from Neuron
Therapeutics, Inc (Malvern, PA). This perfluorocarbon is clear,
colorless, odorless, and immiscible with water or blood, and has
the physical characteristics listed in Table 1.
Experiments
The experimental design is summarized in Figure 1. The
experimental groups included eight animals perfused with
perfluorocarbon. The controls included seven animals in
which saline solution was used as the perfusate (Table 2). In
each case, the animals were stabilized at a fraction of inspired
oxygen (Fio2) of 21% for 30 min, and then were sequentially
dropped to Fio2 values of 18%, 16%, 14%, 12%, and 10% for
30 min at each level. Thirty minutes was an arbitrarily selected
interval based on clinical observations that this interval would
be sufficient to allow equilibration with a change in mechan-
ical ventilation parameters. This time frame was also necessary
due to the logistical constraints of the animal facility to keep
the experiments to  8 h. The desired Fio2 was achieved by
empirically adjusting the blend of nitrogen and oxygen to
achieve the desired Fio2, as indicated by the in-line gas
monitor (Datex; Puritan-Bennett Corporation).
During the progressive hypoxia phase, as the Fio2 descended
from 18 to 10%, the circuit tubing remained clamped with 5 to 7
Table 1—Properties of Perfluorocarbon
Properties Values
Specific gravity 1.668 g/mL
Oxygen capacity 50 volume%
Carbon dioxide capacity 200 volume%
Boiling point 132°C
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L of perfusate dwelling in the abdomen. Arterial and mixed
venous blood gasses, along with heart rate and BP, central venous
pressure, and pulmonary arterial pressures were obtained at each
level. Blood gas measurements were performed (Gem Premier
3000; Instrumentation Laboratory; Lexington, MA). For the first
two experiments in each group, the intraperitoneal pressure was
also recorded, both before and during peritoneal perfusion.
At the conclusion of the descending-Fio2 phase (ie, after the
animals had been at an Fio2 of 10% for 30 min with the circuit
off and the perfusate dwelling in the abdomen), the tubing was
unclamped, and the peritoneal oxygenation circuit was activated
at the previously determined flow rate. The volume of perfusate
that remained in the abdomen during perfusion was also idiosyn-
cratic, remained relatively stable with a stable flow rate, and
ranged from 2 to 3 L. The ascending Fio2 levels were achieved
by resuming the same nitrogen and oxygen flow settings that had
been used for the descending-Fio2 phase. The animals were
again allowed to equilibrate for 30 min during the ascending
phase prior to collecting blood gas measurements. The oxygen
supply to the bubbler was always maintained at 30 psi.
Statistical Analysis
Mixed-effects linear regression was used to model oxygen
uptake as a function of treatment group (ie, perfluorocarbon vs
saline solution groups), oxygenation condition (ie, oxygenation
circuit off vs oxygenation circuit on), and Fio2. Heuristically, this
approach fits a “random” regression line for the Pao2 data of each
animal as a function of Fio2. Then, it statistically averages these
curves within each group and oxygenation condition to obtain the
overall fixed (ie, average) effects. This method appropriately
accounts for unbalanced data due to occasional missing measure-
ments, as well as for the correlation of measurements obtained on
the same animal. The interpretation of the fixed-effects estimates
obtained from the linear regression model is similar to that of the
usual linear regression (ie, in terms of mean Pao2 values and
mean differences). The analyses were conducted using a statisti-
cal software package (SAS, version 8.2; SAS Institute; Cary, NC
[from 1999 to 2001]).
Results
Table 2 summarizes the groups of animals. The
study included eight pigs in the experimental group
(perfluorocarbon) and seven pigs in the control
group (saline solution). All animals underwent the
same experimental protocol with the exception that
liquid was used as the perfusate. The measured
intraperitoneal pressures for steady-state perfusion
were 15 cm H2O. The measured pulmonary artery
pressures were 12 to 18 mm Hg and 4 to 8 mm Hg,
respectively, for the two groups, and were unaffected
by whether the perfusion circuit was running or the
type of perfusate. No statistically significant differ-
ence was noted in the Paco2 or venous Pco2 be-
tween groups, irrespective of Fio2 or whether saline
solution or perfluorocarbon was used as the perfus-
ate.
During the experiments, the animals were ob-
served at five different levels of Fio2 (18%, 16%,
14%, 12%, and 10%) under two different conditions
Figure 1. Experimental design.
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(circuit off or circuit on). A total of 132 measure-
ments were obtained, 69 when the oxygenation
circuit was off and 63 when the oxygenation circuit
was on. Table 3 presents the observed and fitted
mean Pao2 values for all groups.
For the saline solution group, with the circuit off
and saline solution dwelling in the abdomen, as the
Fio2 was lowered from 18 to 10% the mean ( SD)
Pao2 decreased from 65.9 9.7 to 26.6 2.8 mm
Hg, respectively. This provided fitted means of 66.7
mm Hg (95% confidence interval [CI], 61.0 to 72.5
mm Hg) to 22.7 mm Hg (95% CI, 17.0 to 28.3 mm
Hg), respectively. After obtaining data for the ani-
mals at an Fio2 of 10%, the oxygenation circuit was
started. As the Fio2 of the animals was raised from
10 to 18%, the mean Pao2 increased from 28.6 3.9
to 60.5 11.6 mm Hg, respectively. This resulted in
fitted mean values of 25.6 mm Hg (95% CI, 20.1 to
31.1 mm Hg) to 55.9 mm Hg (95% CI, 49.0 to 62.7
mm Hg), respectively. These results are depicted as
fitted means in Figure 2.
Saline solution perfusion with the oxygenation
circuit running was then compared to perfluorocar-
bon perfusion with the oxygenation circuit running
(Fig 3). The data from animals that had oxygenated
saline solution perfusion were compared directly to
those of animals that underwent perfusion with
oxygenated perfluorocarbon. As the Fio2 of the
animals was raised from 10 to 18% with the circuit
running with oxygenated perfluorocarbon perfused,
the mean Pao2 increased from 36.7 8.4 to
68.7 10.4 mm Hg, respectively. This resulted in
fitted mean Pao2 values of 35.2 mm Hg (95% CI,
30.2 to 40.1 mm Hg) to 72.7 mm Hg (95% CI, 66.2
to 79.2 mm Hg), respectively (Fig 2). The average
increase in fitted mean Pao2 with oxygenated per-
fluorocarbon perfusion compared to oxygenated sa-
line solution perfusion ranged from 8.1 to 18.2 mm
Hg. These differences represent the treatment effect
comparing oxygenated perfluorocarbon perfusion to
oxygenated saline solution perfusion. All five differ-
ences are statistically significant. A common treat-
ment effect can be estimated across all Fio2 values,
representing the average mean difference in oxygen
uptake between perfluorocarbon and saline solution
when the oxygenation circuit was running, irrespec-
tive of the level of Fio2 (Table 4). This average was
12.8 mm Hg (95% CI, 7.4 to 18.2 mm Hg;
p  0.001).
The above difference between perfluorocarbon
and saline solution perfusion, when the oxygenation
circuit was running, should be put in the context of
the same difference when the oxygenation circuit
was off and the perfusate was dwelling in the
abdomen (Fig 4). As mentioned above, when oxy-
genation was on, oxygen uptake was significantly
higher in the perfluorocarbon group by 12.8 mm Hg
on average (average difference of fitted mean Pao2
values between perfluorocarbon and saline solution
perfusion at all Fio2 levels) [Fig 2]. When the
oxygenation circuit was off and the perfusate was
dwelling in the abdomen, oxygen uptake was also
statistically significantly higher in the perfluorocar-
bon group than in the comparable saline solution
group. The average mean difference in oxygen up-
take between the perfluorocarbon and saline solu-
tion groups, when the oxygenation circuit was off and
perfusate was dwelling in the abdomen, was 6.4 mm
Hg (fitted mean 95% CI, 0.6 to 12.2 mm Hg;
p  0.034). When comparing the quantitative effects
of the oxygenation circuit (ie, off vs on) between the
groups (perfluorocarbon vs saline solution group) a
positive group-by-oxygenation interaction effect was
noted to be 6.4 mm Hg (95% CI, 1.2 to 14.0;
p  0.095).
The most clinically relevant increase in Pao2 came
at an Fio2 of 14% (Fig 2, 3). The observed effect of
perfluorocarbon compared to that of saline solution
with the oxygenation circuit on demonstrated an
observed mean increase of 15.9 mm Hg with a fitted
mean increase of 13.2 mm Hg (95% CI, 7.8 to 18.6
mm Hg) [Table 4]. This resulted in a baseline mean
Table 2—Experimental Variables*
Variables
Perfusion Medium
p Value
Saline Solution
(n  7)
Perfluorocarbon
(n  8)
Gender 1.0
Male 1 (14) 1 (13)
Female 6 (86) 7 (87)
Weight, kg 49.4  2.8 48.6  2.1 0.51
Flow rate, L/min 2.0  0.9 2.6  1.2 0.28
Volume in peritoneal cavity, L 2.5  0.4 2.7  0.3 0.34
Total volume, L 8.4  1.7 9.1  0.4 0.33
*Values are given as No. (%) or mean  SD.
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Pao2 of 39.4 5.0 mm Hg with oxygenated saline
solution perfusion, and a mean Pao2 of 55.3 7.6
mm Hg with oxygenated perfluorocarbon perfusion.
For the observed means, this corresponds to an
increase in arterial oxygen saturation (Sao2) from
73% with oxygenated saline solution perfusing the
abdomen to 89% with oxygenated perfluorocarbon
perfusing the abdomen.
Discussion
These results of our principle experiments repre-
sent the first demonstration of the ability to perform
peritoneal perfluorocarbon perfusion in a large ani-
mal resulting in the augmentation of systemic arterial
oxygenation. Small-animal studies18–21 have previ-
ously demonstrated the ability to use the peritoneal
surface to deliver oxygen using intraperitoneal gas-
eous oxygen, oxygenated saline solution, or oxygen-
ated perfluorocarbon, but promising results have not
previously been reported in any large-animal studies.
The relative ease with which oxygenation can be
increased in small-animal models, but not large-
animal models, is likely a function of the significantly
increased ratio of the peritoneal surface to body mass
in small animals.22 Based on our results, we hypoth-
Figure 2. Perfluorocarbon vs saline solution with oxygenation circuit off and on. Data points represent
observed measurements, while the lines are fitted.
Table 3—Observed and Fitted PaO2 Values for the Saline Solution and Perfluorocarbon Groups, by Oxygenation
Circuit Condition and FIO2
Fio2, % O2
Patients,
No.
Saline Solution Group
Patients,
No.
Perfluorocarbon Group
Observed Fitted Observed Fitted
Mean SD Mean 95% CI Mean SD Mean 95% CI
10 Off 5 26.6 2.8 22.7 17.0–28.3 7 28.0 5.3 25.7 20.6–30.7
12 6 31.3 3.3 33.7 29.0–38.4 8 37.1 8.1 38.5 34.3–42.7
14 6 41.2 4.5 44.7 40.4–49.1 8 48.8 11.4 51.3 47.3–55.3
16 7 57.6 4.9 55.7 51.0–60.5 7 63.7 7.9 64.2 59.7–68.6
18 7 65.9 9.7 66.7 61.0–72.5 8 79.8 7.7 77.0 71.6–82.4
10 On 5 28.6 3.9 25.6 20.1–31.1 7 36.7 8.4 35.2 30.2–40.1
12 6 31.3 4.1 33.2 28.9–37.4 8 43.8 4.8 44.5 40.8–48.3
14 5 39.4 5.0 40.7 36.6–44.8 7 55.3 7.6 53.9 50.2–57.6
16 5 46.2 5.8 48.3 43.2–53.4 7 64.4 8.2 63.3 58.5–68.1
18 6 60.5 11.6 55.9 49.0–62.7 7 68.7 10.4 72.7 66.2–79.2
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esize that a perfusion circuit, with a medium like
perfluorocarbon that is capable of carrying and
unloading large quantities of oxygen, is necessary to
achieve significant gas exchange through the perito-
neal surface of a large animal.
The measured augmentation of systemic oxygen
levels by perfusing the peritoneum with oxygenated
perfluorocarbon was uniform and statistically signif-
icant for all five levels of induced hypoxia. It was the
use of perfluorocarbon that resulted in the observed
phenomenon, in our model, as saline solution failed
to serve as an effective gas transport medium.
The animals that had perfluorocarbon dwelling in
their abdomen, during the progressive hypoxia phase
of the experiments (Fig 1), also had higher oxygen
levels than the corresponding animals that had saline
solution dwelling in their abdomens during this
portion of the experiments (Fig 2, 4). Our hypothesis
to explain this consistent finding is that the volume of
indwelling perfluorocarbon in the abdomen likely
served as an oxygen reservoir and resulted in blunt-
ing of the induced hypoxia effect on arterial oxygen
concentrations as the Fio2 was decreased from 18 to
10%. Although we were unable to directly measure
the oxygen content of the perfluorocarbon, the per-
fluorocarbon would have initially equilibrated with
atmospheric air, a Po2 of approximately 160 mm Hg,
and could have held as much as 2.5 to 3.5 L of
available oxygen.14–17 Given the rapidity with which
gradient-driven gasses dissolve in perfluorocarbons
and the fact that tissues extract essentially all oxygen
from perfluorocarbons before extracting oxygen
from hemoglobin, one would assume that the dwell-
ing perfluorocarbon served as a renewable oxygen
reservoir as the animals were rendered progressively
hypoxic.23 That is, in addition to serving as an initial
oxygen reservoir, it is likely that the reservoir was
relatively “renewed” as the animals progressed from
higher to lower levels of inspired oxygen. For exam-
ple, if an animal was at an Fio2 level of 16%, the
perfluorocarbon would equilibrate to the tissues at
this level and would then be higher than the tissue
levels when the Fio2 was decreased to 14%, thereby
serving as a source of oxygen at the 14% Fio2 level.
It is interesting to note that saline solution, dwell-
ing in the abdomen or with the oxygenation circuit
running, and perfluorocarbon, dwelling in the abdo-
men but without progressing to a lower Fio2, yielded
essentially the same arterial oxygen concentrations at
the lowest Fio2 of 10% (Fig 2). At this point, only
Figure 3. Perfluorocarbon vs saline solution with oxygenation circuit on.
Table 4—Observed and Estimated Treatment Effect:
Mean PaO2 Difference Between Perfluorocarbon vs
Saline Solution, With Oxygenation Circuit on, for
Different FIO2 Values
Fio2, %
Observed
Effect
Fitted
p ValueEffect 95% CI
10 8.1 9.6 3.3–15.9 0.005
12 12.4 11.4 5.9–16.9 0.001
14 15.9 13.2 7.8–18.6 0.001
16 18.2 15.0 8.9–21.1 0.001
18 8.2 16.8 9.4–24.3 0.001
Overall 12.8 7.4–18.2 0.001
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activation of the oxygenation circuit, in the perfluo-
rocarbon animals, resulted in increased arterial oxy-
gen levels (Fig 2). Examining the data at this lowest
level of induced hypoxia is as close as we could come
to eliminating the reservoir effect from our data. The
necessity of maintaining a stagnant volume of per-
fusate in the abdomen during the progressive hyp-
oxia measurements was a limitation of our experi-
mental model.
Another consistent trend, likely resulting from the
limitations of our model, is the fact that all animals
demonstrated their highest arterial oxygen concen-
trations at the initiation of the experiments, with the
oxygenation circuits not running. Our experiments
were designed to ferret out any potential effect from
peritoneal perfusion. To magnify the effect from a
gradient-driven phenomenon, we elected to drop the
animals to the profound level of hypoxia induced by
ventilating them with an Fio2 of 10%. In retrospect,
this degree of hypoxia is clinically irrelevant and
likely placed the animals into a state of oxygen debt
from which they could never recover during the
ascending phase of the induced hypoxia measure-
ments (Fig 1). It is our hypothesis that this state of
oxygen debt at the conclusion of the experiments is
why all the animals demonstrated their highest levels
of oxygenation at the beginning of the experiments,
when they first entered a state of induced hypoxia
(Fig 2). We also feel that the parallel sequence of
induced hypoxia increase and decrease, for both the
saline solution and perfluorocarbon groups, is why
the resulting data yielded parallel lines (Fig 2) for
perfusate that was dwelling in the abdomen and
perfusate that was circulating. Although the results
of our principle experiments demonstrate that arte-
rial oxygenation can be supplemented by instilling
perfluorocarbon into the abdomen, partially with
dwelling and more so by circulating oxygenated
perfluorocarbon, it is important to view these results
within the context of the short duration of the
experiments, the peculiarities of our induced hypoxia
model, and the statistically significant, but relatively
small, sample size of our study.
We designed this model to allow us to explore the
effect of perfusion over a wide range of hypoxia. In
order to specifically study the effects on oxygenation,
we maintained the animals in a normocarbic state
and, thus, cannot draw any conclusions regarding the
impact of peritoneal perfluorocarbon perfusion to
clear carbon dioxide. One could speculate, however,
that the greater diffusivity of carbon dioxide com-
pared to oxygen, and the very high solubility of
carbon dioxide in perfluorocarbon would favor car-
bon dioxide clearance in a hypercarbic state.
In considering peritoneal perfusion as a potential
treatment for patients with reversible pulmonary
failure, arterial oxygen levels in the 40 mm Hg range
might represent the point at which a clinician would
entertain instituting heroic measures for appropriate
patients. This degree of hypoxia was achieved in our
model at an Fio2 of 14%, which resulted in a mean
arterial oxygen concentration of 39.4 mm Hg with
oxygenated saline solution perfusion, and an Sao2 of
73%. Perfusing the abdomen with oxygenated per-
Figure 4. Perfluorocarbon vs saline solution with oxygenation circuit off.
www.chestjournal.org CHEST / 130 / 2 / AUGUST, 2006 409
 © 2006 American College of Chest Physicians
 at Thomas Jefferson University on March 7, 2012chestjournal.chestpubs.orgDownloaded from 
fluorocarbon, compared to perfusing it with oxygen-
ated saline solution, resulted in an average difference
of 15.9 mm Hg of oxygen, which correlated with an
average arterial oxygen level of 55.3 mm Hg. This
corresponded to an average increase in the Sao2
from 73 to 89%. Although our experiments were
short term, and strictly proof of principle, it is worth
noting that this degree of augmentation in oxygen-
ation could represent a potentially life-saving mea-
sure in a patient dying from reversible pulmonary
failure.
The amount of oxygen delivery that we observed is
significantly less than can be achieved with direct
blood interface techniques, like extracorporeal mem-
brane oxygenation. Peritoneal perfusion, however,
would not require anticoagulation, and this is a
potentially significant advantage. For example, a
trauma patient with an intracranial hemorrhage and
pulmonary contusions or ARDS may require ex-
trapulmonary oxygen delivery but would not be a
candidate for any modality requiring anticoagulation.
If further research reveals that this modality re-
mains as innocuous for prolonged periods as we
observed for these short-term proof-of-principle ex-
periments, then there could be other roles for this
modality beyond the salvage of a patient in terminal
pulmonary failure. Another potential application
would be to initiate this treatment in a prophylactic
manner to prevent or limit ventilator-induced lung
injury.24 As a nonpulmonary technique for gas ex-
change, it could allow the clinician to decrease the
toxic ventilator settings that are sometimes required
to support a patient who is dying from potentially
reversible lung failure. Such a technique could short
circuit the “catch-22” that results when high ventila-
tor settings exacerbate the underlying lung dysfunc-
tion and mandate even higher ventilator settings,
further worsening the dysfunction. From a technical
surgical perspective, it would not be difficult to
institute this type of treatment at the bedside.
Conclusion
The results from these proof-of-principle exper-
iments demonstrate that systemic oxygen levels
can be increased in a large-animal induced hypoxia
model by perfusing the peritoneal surface with
oxygenated perfluorocarbon. The gas-dissolving
and gas-unloading properties of perfluorocarbon
were necessary as the same effect was not obtained
when saline solution was employed as the perfus-
ate. Although supplemental oxygenation has been
demonstrated in small animals (with their rela-
tively larger peritoneal surface) by using various
techniques to oxygenate the abdominal cavity, this
is the first demonstration of investigators being
able to consistently accomplish this objective in a
large animal. Further studies are indicated and
will take the form of longer duration peritoneal
perfusion runs to look for toxic side effects of this
treatment, the evaluation of the impact of this
technique on carbon dioxide clearance, the per-
formance of this technique in disease models that
simulate human conditions of severe pulmonary
failure, and the exploration of interventions that
can enhance gas exchange across the peritoneal
membrane. We speculate that this technique
could potentially find a role in the supportive care
of patients with profound, but reversible, pulmo-
nary failure. As this is a pulmonary-independent
technique for supplementing oxygenation, there
could even be a role for treating patients with less
severe, but worsening, pulmonary failure in order
to prevent the compounding problem of ventila-
tor-induced lung injury.
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